May 15, 2020 / 1:30 PM / 16 days ago

BRIEF-Rubius Therapeutics To Present RTX-321 Preclinical Data At American Association Of Cancer Research Annual Meeting

May 15 (Reuters) - Rubius Therapeutics Inc:

* RUBIUS THERAPEUTICS TO PRESENT PRECLINICAL DATA FOR RTX-321, A RED CELL THERAPEUTIC™ ONCOLOGY PRODUCT CANDIDATE FOR HPV-POSITIVE CANCERS AT THE AMERICAN ASSOCIATION OF CANCER RESEARCH ANNUAL MEETING Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below